Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Gerard Crotty"'
Publikováno v:
Case Reports in Hematology, Vol 2013 (2013)
Mutations of MPL are present in a significant proportion of patients with the myeloproliferative neoplasms (MPN), primary myelofibrosis (PMF), and essential thrombocythaemia (ET). The most frequent of these mutations, W515L and W515K, occur in exon 1
Externí odkaz:
https://doaj.org/article/982bf98ac79e4f83ad3258fdf80df7ab
Autor:
Robert B. Henderson, Brian Hennessy, Christopher L. Bacon, Patrick Thornton, Richard Flavin, David O'Brien, Fiona Quinn, Hilary O'Leary, Anita Dowling, Michael O'Dwyer, Helen Fogarty, Steve Langabeer, James Nolan, Elisabeth Vandenberghe, Gerard Crotty
Publikováno v:
Irish Journal of Medical Science (1971 -). 190:1087-1094
Introduction Biclonal lymphoid disorders, when two distinct lymphoproliferative disorders (LPD) co-exist, are rare (incidence of 1.4%) and associated with a poor prognosis. NOTCH1 mutations occur in 10% of CLL at diagnosis, associated with a short di
Autor:
Meletios A. Dimopoulos, Kari Remes, Joana Parreira, Pamela Bacon, Eleni Tholouli, Bjorn Andreasson, Gianpietro Semenzato, Gerard Crotty, Elisabeth Kueenburg, Christian Berthou, Miguel T. Hernandez, Monique C. Minnema, Sarah Peters, Antonia Di Micco, B. Rosettani, Igor Wolfgang Blau, Roman Hájek, Jo Caers, Barbara Gamberi
Publikováno v:
Clinical Lymphoma, Myeloma & Leukemia
Clinical Lymphoma, Myeloma & Leukemia, Elsevier, 2020, 20 (10), pp.e629-e644. ⟨10.1016/j.clml.2020.05.006⟩
Clinical Lymphoma, Myeloma & Leukemia, Elsevier, 2020, 20 (10), pp.e629-e644. ⟨10.1016/j.clml.2020.05.006⟩
Introduction Lenalidomide plus dexamethasone is effective and well tolerated in relapsed/refractory multiple myeloma (RRMM). In this observational, noninterventional European post-authorization safety study, the safety profile of lenalidomide plus de
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Blood Cells, Molecules, and Diseases. 90:102593
Autor:
Mary R. Cahill, Kathleen Scott, Johanna Kelly, Hilary O'Leary, Michael O'Dwyer, Fiona Quinn, Andrew Hodgson, Elisabeth Vandenberghe, Niamh Appleby, Gerard Crotty, Brian Hennessy, Liam Smyth, Helen Enright, Imelda Parker, Maeve Leahy, Amjad Hayat, David O'Brien
Publikováno v:
Leukemia & Lymphoma. 59:1338-1347
Minimal residual disease negative complete response (MRD-negative CR) provides an early marker for time to treatment failure (TTF) in CLL treated with fludarabine, cyclophosphamide, and rituximab (FCR). MRD was assessed after four FCR cycles (FCR4);
Autor:
Helen, Fogarty, Anita, Dowling, David, O'Brien, Steve, Langabeer, Christopher Laurence, Bacon, Richard, Flavin, Michael, O'Dwyer, Brian, Hennessy, Hilary, O'Leary, Gerard, Crotty, Robert, Henderson, James, Nolan, Patrick, Thornton, Elisabeth, Vandenberghe, Fiona, Quinn
Publikováno v:
Irish journal of medical science. 190(3)
Biclonal lymphoid disorders, when two distinct lymphoproliferative disorders (LPD) co-exist, are rare (incidence of 1.4%) and associated with a poor prognosis. NOTCH1 mutations occur in 10% of CLL at diagnosis, associated with a short disease-free in
Autor:
Gerard Crotty
Publikováno v:
Learning Disability Practice. 19:32-37
Autor:
Gerard Crotty, Owen Doody
Publikováno v:
Learning Disability Practice. 18:25-29
Autor:
Gerard Crotty, Owen Doody
Publikováno v:
Learning Disability Practice. 18:33-37